Evidence of IL-17, IP-10, and IL-10 involvement in multiple-organ dysfunction and IL-17 pathway in acute renal failure associated to Plasmodium falciparum malaria

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Herbert, Fabien ^a   Tchitchek, Nicolas ^b   Bansal, Devendra ^a   Jacques, Julien ^c   Pathak, Sulabha ^d   Bécavin, Christophe ^e   Fesel, Constantin ^f   Dalko, Esther ^a   Cazenave, Pierre André ^a,g   Preda, Cristian ^c   Ravindran, Balachandran ^h   Sharma, Shobhona ^f   Das, Bidyut ⁱ   Pied, Sylviane ^a  

^a UNIV LILLE   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c INRIA   (France)

^d TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

^e INSTITUT PASTEUR   (France)

^f INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^g Sorbonne Université   (France)

^h INSTITUTE OF LIFE SCIENCES   (India)

ⁱ SCB MEDICAL COLLEGE   (India)

Author keywords

Acute renal failure; Biomarkers; Cerebral malaria; Cytokines; IL 17; Malaria associated organ failure; Plasmodium falciparum; Severe malaria

Indexed keywords

ALPHA2 INTERFERON; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; ASSAY; BRAIN MALARIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTIPLE ORGAN FAILURE; MULTIPLEX ASSAY; PROTEIN BLOOD LEVEL; SEPSIS; VIRUS ENCEPHALITIS; BLOOD; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; CHEMOKINE CXCL10; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; MALARIA, FALCIPARUM; MULTIPLE ORGAN FAILURE;

EID: 84947910604     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0731-6     Document Type: Article

References (45)

1. World Health Organization. World malaria report 2013 [Internet]. Nature. 2013. http://www.who.int.
2. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 1999;77:624-40.
3. Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg. 2007;77:69-78.
4. Mishra SK, Panigrahi P, Mishra R, Mohanty S. Prediction of outcome in adults with severe falciparum malaria: a new scoring system. Malar J. [Internet]. 2007;6:24. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1808463&tool=pmcentrez&rendertype=abstract.
5. Das BS. Renal failure in malaria. J Vector Borne Dis. 2008;45:83-97.
6. Mazier D, Nitcheu J, Idrissa-Boubou M. Cerebral malaria and immunogenetics. Parasite Immunol. 2000;22:613-23.
7. Grau GE, de Kossodo S. Cerebral malaria: mediators, mechanical obstruction or more? Parasitol Today. 1994;10:408-9.
8. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature. 1989;341:57-9.
9. Hommel M. Cytoadherence of malaria-infected erythrocytes. Blood Cells. 1990;16:605-19.
10. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24:491-9.
11. Miller KL, Silverman PH, Kullgren B, Mahlmann LJ. Tumor necrosis factor alpha and the anemia associated with murine malaria. Infect Immun. 1989;57:1542-6.
12. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990;336:1201-4.
13. Mirghani HA, Eltahir HG, A-elgadir TM, Mirghani YA, Elbashir MI, Adam I. Cytokine profiles in children with severe Plasmodium falciparum malaria in an area of unstable malaria transmission in central sudan. J Trop Pediatr. 2011;57:392-5.
14. John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis. 2006;194(6):837-45 (Epub 2006 Aug 16).
15. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, et al. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun. 2004;72:5630-7.
16. Kurtzhals JAL, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, et al. Low plasma concentrations of interleukin-10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998;351:1768-72.
17. Peyron F, Burdin N, Ringwald P, Vuillez JP, Rousset F, Banchereau J. High levels of circulating IL-10 in human malaria. Clin Exp Immunol. 1994;95:300-3.
18. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, Riley EM. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis. 2002;185:971-9.
19. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, et al. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis. 1999;179:980-8.
20. Clark IA, Rockett KA. The cytokine theory of human cerebral malaria. Parasitol. Today. 1994;10:410-2.
21. Baptista JL, Vanham G, Wéry M, Van Marck E. Cytokine levels during mild and cerebral falciparum malaria in children living in a mesoendemic area. Trop Med Int Health. 1997;2:673-9.
22. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis. 1999;180:1288-97.
23. Prakash D, Fesel C, Jain R, Cazenave P-A, Mishra GC, Pied S. Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis. 2006;194:198-207.
24. National Vector Borne Disease Control Programme. http://nvbdcp.gov.in/malaria-new.html. Accessed in July 2014.
25. Panda AK, Panda SK, Sahu AN, Tripathy R, Ravindran B, Das BK. Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar J. 2011;10:309.
26. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000;94(Suppl 1):S1-90.
27. Bécavin C, Tchitchek N, Mintsa-Eya C, Lesne A, Benecke A. Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition. Bioinformatics. 2011;27:1413-21.
28. Kruskal JB, Wish M. Multidimensional scaling. Methods [Internet]. 1978;116:463-504. http://www.springerlink.com/index/10.1007/978-0-387-78189-174;19.
29. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1942.
30. De Berg M, Cheong O, Van Kreveld M, Overmars M. Computational geometry: algorithms and applications [Internet]. Comput. Geom. 2008. http://www.google.com/books?id=tkyG8W2163YC.
31. Pathak S, Rege M, Gogtay NJ, Aigal U, Sharma SK, Valecha N, Bhanot G, Kshirsagar NA, Sharma S. Age-dependent sex bias in clinical malarial disease in hypoendemic regions. PLoS One. 2012;7:e35592.
32. Brown H, Turner G, Rogerson S, Tembo M, Mwenechanya J, Molyneux M, et al. Cytokine expression in the brain in human cerebral malaria. J Infect Dis. 1999;180:1742-6.
33. Boeuf PS, Loizon S, Awandare GA, Tetteh JK, Addae MM, Adjei GO, et al. Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia. Malar J. 2012;11:253.
34. Ho M, Sexton MM, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster HK. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis. 1995;172:838-44.
35. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovère C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol. 2010;224:93-100.
36. Yamagami S, Tamura M, Hayashi M, Endo N, Tanabe H, Katsuura Y, et al. Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J Leukoc Biol. 1999;65:744-9.
37. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS. 1998;12:1327-32.
38. Campanella GSV, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA. 2008;105:4814-9.
39. Nie CQ, Bernard NJ, Norman MU, et al. IP-10-Mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 2009;5:e1000369-e1000369.
40. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J. 2008;7:83.
41. Turner JE, Paust HJ, Steinmetz OM, Panzer U. The Th17 immune response in renal inflammation. Kidney Int. 2010;77:1070-5. doi: 10.1038/ki.2010.102.
42. Duvallet E, Semerano L, Assier E, Falgarone G, Boissier MC. Interleukin-23: a key cytokine in inflammatory diseases. Ann Med. 2011;43:503-11. doi: 10.3109/07853890.2011.577093.
43. Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585-600. doi: 10.1038/nri3707.
44. Van Nieuwenhuijze A, Koenders M, Roeleveld D, Sleeman MA, van den Berg W, Wicks IP. GM-CSF as a therapeutic target in inflammatory diseases. Mol Immunol. 2013;56:675-82.
45. Noster R, Riedel R, Mashreghi MF, Radbruch H, Harms L, Haftmann C, Chang HD, Radbruch A, Zielinski CE. IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci Transl Med. 2014 18;6(241):241ra80. doi: 10.1126/scitranslmed.3008706.